Relay Therapeutics Inc.
RLAY | NASDAQ
$18.54
+$0.35 (+1.92%)
Sep 22, 2026, 11:22 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 15.36M | 10.01M | 25.55M | 1.38M | 3.03M | 82.65M |
Cost of Revenue | 3.56M | 315.44M | 326.39M | 243.01M | 169.39M | 3.55M |
Gross Profit | 11.8M | -305.43M | -300.84M | -241.62M | -166.36M | 79.11M |
Operating Income | -302.74M | -372.47M | -373M | -299.28M | -364.7M | -55.8M |
Interest Income | 27.04M | 34.75M | 31.05M | 8.79M | 830K | 3.4M |
Pretax Income | -276.48M | -337.71M | -341.97M | -290.51M | -363.87M | -52.41M |
Net Income | -276.48M | -337.71M | -341.97M | -290.51M | -363.87M | -52.41M |
Selling & General & Admin | 56.71M | 80.24M | 78.58M | 69.33M | 59.75M | 38.59M |
Research & Development | 261.38M | 319.09M | 330.02M | 246.36M | 295.65M | 99.86M |
Other Expenses | -3.56M | -332.3M | -336.44M | -258.03M | -157.06M | -3.55M |
Operating Expenses | 314.54M | 67.03M | 72.16M | 57.65M | 198.34M | 134.9M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 4.24M | 4.25M | 4.24M | 4.26M | n/a |
Cost & Expenses | 318.09M | 382.48M | 398.55M | 300.66M | 367.73M | 138.45M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 171.59M | 142.87M | 122.58M | 112.23M | 95.14M | 90.05M |
Shares Outstanding (Diluted) | 171.59M | 142.87M | 122.58M | 112.23M | 95.14M | 90.19M |
EPS (Basic) | -1.61 | -2.36 | -2.79 | -2.59 | -3.82 | -2.56 |
EPS (Diluted) | -1.61 | -2.36 | -2.79 | -2.59 | -3.82 | -2.56 |
EBITDA | -272.92M | -380.21M | -374.15M | -306.82M | -223.08M | -52.25M |
EBIT | -276.48M | -385.67M | -379.42M | -310.95M | -227.01M | -55.8M |
Depreciation & Amortization | 3.56M | 5.46M | 5.27M | 4.13M | 3.93M | 3.55M |
Add to Watchlist
Select watchlists to add or remove RLAY